MétaCan
Menu
Back to cohort
Record W4416111801 · doi:10.1097/js9.0000000000003886

Effect of intravenous tirofiban on the efficacy and safety of stent retriever versus aspiration first-line thrombectomy: secondary analysis of the RESCUE BT trial

2025· article· en· W4416111801 on OpenAlexaboutno aff
Weilin Kong, Guojian Liu, Tao Zhang, Chenggang Du, Xiaona Wu, Xiwu Zhang, Kuihong Cheng, Changwei Guo, Shitao Fan, Xiaolei Shi, Shihai Yang, Junjie Yuan, Fengli Li, Wenjie Zi

Bibliographic record

VenueInternational Journal of Surgery · 2025
Typearticle
Languageen
FieldMedicine
TopicCoronary Interventions and Diagnostics
Canadian institutionsnot available
Fundersnot available
KeywordsTirofibanPerioperativeLabrador RetrieverRandomized controlled trialSubgroup analysisStent

Abstract

fetched live from OpenAlex

BACKGROUND: Tirofiban is increasingly used as an adjuvant medication during endovascular thrombectomy (EVT) in acute ischemic stroke. We investigated the influence of intravenous tirofiban versus placebo on the clinical outcomes of first-line thrombectomy strategies. METHODS: This secondary analysis of the RESCUE BT (The Endovascular Treatment With Versus Without Tirofiban for Patients with Large Vessel Occlusion Stroke) trial included patients who underwent EVT with a stent retriever (with or without aspiration) or aspiration thrombectomy technique as the first-line strategy. We compared clinical and safety outcomes between stent retrievers and aspiration thrombectomy as first-line EVT strategy and evaluated the interactions with intravenous tirofiban. The primary outcome was the modified Rankin Scale (mRS) score at 90 days follow-up, analyzed using ordinal regression for a shift toward better outcome. Secondary outcomes included angiographic outcomes and symptomatic intracranial hemorrhage (sICH) within 48 hours and 90-day mortality. Multivariable regression analyses with interaction terms were performed. RESULTS: Among the 830 included patients, 464 (55.9%) were treated with a stent retriever as first-line strategy, including 212 (45.7%) patients in tirofiban group. There was no difference in the distribution of mRS score between stent retriever versus aspiration groups [adjusted common odds ratio (acOR) 1.26 (95% CI, 0.99-1.61), P = 0.07], and tirofiban did not improved outcome compared to placebo [acOR, 1.07 (95% CI, 0.84-1.37), P = 0.56]. Intravenous tirofiban may potentially enhance the efficacy of first-line stent retriever thrombectomy by increasing the rates of complete reperfusion [aOR, 1.43 (95% CI, 0.98-2.08), P = 0.06] and first-pass effect [aOR, 1.45 (95% CI, 0.97-2.18), P = 0.07], whereas intravenous tirofiban may potentially enhance the risk of sICH [aOR, 2.10 (95% CI, 0.93-4.43), P = 0.08] in first-line aspiration thrombectomy. No significant interaction between intravenous tirofiban and first-line EVT strategy was found for the clinical and safety outcomes. CONCLUSIONS: In RESCUE BT trial, the treatment effect of perioperative intravenous tirofiban was not influenced by the first-line EVT strategy. In both first-line stent retriever thrombectomy and aspiration thrombectomy groups, we observed no significant differences in the clinical outcomes with the adjunctive use of intravenous tirofiban. Randomized controlled trials are needed to confirm these findings.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.725
Threshold uncertainty score0.345

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.032
GPT teacher head0.323
Teacher spread0.291 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueInternational Journal of SurgerySame topicCoronary Interventions and DiagnosticsFrench-language works237,207